According to SPER Market Research analysis, the
global in-vitro diagnostics market is bolstering market growth owing to rising chronic diseases and development in advance technology.
The global in-vitro diagnostics market size is projected to reach USD 110.0 billion by 2028 at a CAGR of 3.8% during the forecast period. With the changing lifestyle of people, there are higher requirements for disease risk prediction, health management, chronic disease management, etc. The In-vitro diagnostic market has vast room for development, especially in regions and countries with underdeveloped medical standards.
Companies Covered
- Abbott Laboratories
- Becton
- Dickinson and Company
- bioMérieux SA
- Bio-Rad Laboratories Inc.
- Danaher Corporation (Beckman Coulter, Inc.)
- F. Hoffmann-La Roche Ltd.
- Johnson & Johnson
- QIAGEN N.V.
- Sysmex Corporation
- Thermo Fisher Scientific Inc.
- and others are the key players.
Reasons to buy this report
- This SPER Market Research report will help to develop business strategies by understanding the trends shaping and driving the global in-vitro diagnostics market.
- Organize sales and marketing efforts by identifying the best opportunities for the global in-vitro diagnostics market.
To understand the future market competition in the global in-vitro diagnostics market.
The report is based on in-depth qualitative and quantitative analysis of the global in-vitro diagnostics market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.
Browse report overview on "Global In-Vitro Diagnostics Market - By Product Type (Reagents, Instruments, and Software & Services), By Technique (Immunodiagnostics, Hematology, Molecular Diagnostics, Tissue Diagnostics, Clinical Chemistry, and Other IVD Techniques), By Application (Infectious Diseases, Cancer, Cardiac Diseases, Immune System Disorders, Nephrological Diseases, Gastrointestinal Diseases, and Other Indications), and By End User (Standalone Laboratory, Hospitals, Academic & Medical Schools, Point of Care Testing, and Others)and By Region (North America, Europe, Asia Pacific, South America, and Middle East, & Africa)- Global forecast from 2021-2028" at:
https://www.sperresearch.com/report-store/In-Vitro-Diagnostics.aspx